XML 167 R4.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDER'S EQUITY - USD ($)
Class A share capital
Class B share capital
Warrants
Contributed surplus
Foreign exchange translation reserve
Accumulated deficit
Total
Beginning balance at Dec. 31, 2018 $ 151,588 $ 51,093,434 $ 3,341,826 $ 3,744,423   $ (19,939,575) $ 38,391,696
Beginning balance (shares) at Dec. 31, 2018 72 6,843,780 546,212        
Shares issued   $ 8,681,103 $ 0       8,681,103
Shares issued (shares)   408,651 0        
Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc.   $ 12,361,657 $ 1,420,407 1,931,384     15,713,448
Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc. (shares)   510,940 67,598        
Share options exercised       12,082,930     12,082,930
Share based payments   $ 1,340,929   (789,794)     551,135
Share-based payments (shares)   130,189          
Warrants exercised   $ 109,214 $ (37,753)       71,461
Warrants exercised (shares)   12,167 (12,167)        
Warrants expired     $ (402,491) (402,491)      
Warrants expired (shares)     (134,192)        
Comprehensive loss for the year         $ (84,776) (39,129,520) (39,214,296)
Ending balance at Dec. 31, 2019 $ 151,588 $ 73,586,337 $ 4,321,989 17,371,434 (84,776) (59,069,095) 36,277,477
Ending balance (shares) at Dec. 31, 2019 72 7,905,727 467,451        
Shares issued   $ 22,242,975 $ 1,110,904 (1,302,076)     22,051,803
Shares issued (shares)   8,925,942 6,335,758        
Share options exercised   $ 563,747   (504,185)     59,562
Share options exercised (shares)   22,382          
Share based payments   $ 6,663,479   2,763,482     9,426,961
Share-based payments (shares)   2,307,569          
Warrants expired     $ (463,935) (463,935)      
Warrants expired (shares)     (54,100)        
Comprehensive loss for the year         292,573 (31,799,793) (31,507,220)
Ending balance at Dec. 31, 2020 $ 151,588 $ 103,056,538 $ 4,968,958 18,792,590 207,797 (90,868,888) 36,308,583
Ending balance (shares) at Dec. 31, 2020 72 19,161,620 6,749,109        
Shares issued   $ 38,341,407         38,341,407
Shares issued (shares)   15,480,462          
Share based payments   $ 3,751,412 $ 98,513 3,594,006     7,443,931
Share-based payments (shares)   1,462,558 100,000        
Lucid acquisition   $ 7,023,732 $ 70,563 196,436     7,290,731
Lucid acquisition (shares)   4,502,392 112,162        
Share cancelation (shares)   (156,278)          
Warrants expired     $ (617) (617)      
Warrants expired (shares)     (4,476)        
Comprehensive loss for the year         31,815 (35,285,429) (35,253,614)
Ending balance at Dec. 31, 2021 $ 151,588 $ 152,173,089 $ 5,137,417 $ 22,583,649 $ 239,612 $ (126,154,317) $ 54,131,038
Ending balance (shares) at Dec. 31, 2021 72 40,450,754 6,956,795